Neutral on Eris Lifesciences, target price Rs 930: Motilal Oswal

Motilal Oswal has neutral call on Eris Lifesciences Ltd. with a target price of Rs 930. The current market price of Eris Lifesciences Ltd. is Rs 846.

Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 11507.99 Crore) operating in Pharmaceuticals sector.

Eris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.



Financials
For the quarter ended 31-12-2023, the company reported a Consolidated Total Income of Rs 490.49 Crore, down -3.59 % from last quarter Total Income of Rs 508.78 Crore and up 15.28 % from last year same quarter Total Income of Rs 425.50 Crore. Company reported net profit after tax of Rs 101.46 Crore in latest quarter.


Promoter/FII Holdings
Promoters held 54.9 per cent stake in the company as of 31-Dec-2023, while FIIs owned 13.13 per cent, DIIs 14.55 per cent.